Results 191 to 200 of about 341,151 (335)
Psilocybin as a novel treatment for chronic pain
Abstract Psychedelic drugs are under active consideration for clinical use and have generated significant interest for their potential as anti‐nociceptive treatments for chronic pain, and for addressing conditions like depression, frequently co‐morbid with pain.
Tate Askey +3 more
wiley +1 more source
Psychedelics, entactogens and psychoplastogens for depression and related disorders
Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N,N‐dimethyltryptamine, ayahuasca; non‐hallucinogenic entactogens, e.g. MDMA; psychoplastogens which rapidly promote neuroplasticity, e.g.
Daniel Hoyer
wiley +1 more source
IgE Nonresponders in Basophil Activation Tests: A Narrative Review From Mechanistic Insights to Clinical Implications and Future Directions. [PDF]
Eberlein B, Biedermann T.
europepmc +1 more source
Effects of intraduodenally applied bile salts on pancreatic secretion [PDF]
Lehnert, Peter, Riepl, Rudolf L.
core +1 more source
Histamine release in the isolated vascularly perfused stomach of the rat: regulation by autoreceptors [PDF]
Arne K. Sandvik +2 more
openalex +1 more source
Non‐canonical PKG1 regulation in cardiovascular health and disease
It is well established that the cyclic GMP‐dependent protein kinase I (PKG1) is canonically activated by cyclic guanosine monophosphate (cGMP), enabling its regulation of vascular tone, cardiac function and smooth muscle homeostasis. However, diverse non‐canonical stimuli of PKG1 have also been identified.
Jie Su, Joseph Robert Burgoyne
wiley +1 more source
A New Approach to the Determination of Biogenic Amines in Wine. [PDF]
Salimova A +4 more
europepmc +1 more source
Formation of Histamine and Other Biogenic Amines During Storage of Freshwater Fish Chunks
R. Jeya Shakila, T. S. Vasundhara
openalex +2 more sources

